James E. Wagner Cultivation Corporation (TSX VENTURE:JWCA) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement dated July 31, 2018 with MediPharm Labs Inc. ("MediPharm") further to the Company’s press release dated June 18, 2018. Pursuant to the Agreement, the parties have entered into a commercial arrangement whereby JWC will provide MediPharm with dried cannabis to use for the purposes of creating cannabis oil.
Read more
MediPharm Labs Inc. Signs Cannabis Concentrate Program Agreement With James E. Wagner Cultivation Corporation
